IOF-ESCEO congress will focus on advances in the management of musculoskeletal diseases

January 14, 2014

With the ageing of the population, health authorities all over the world are expecting a dramatic increase in the number of people suffering from chronic diseases of bone, muscle and joints. The IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases has become an important educational and research forum to help physicians meet the growing challenge posed by these serious diseases.

Held annually in Europe, the Congress is jointly organized by the International Osteoporosis Foundation (IOF) and the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). In 2014 the Congress will take place from April 2-5 in Seville, Spain.

Delegates will include leading researchers and health professionals from a broad spectrum of specializations, including rheumatology, endocrinology, orthopedics, radiology, general practice, and rehabilitation. CME accreditation is expected (application in process).

Accepted abstracts (submission possible until January 16, 2014) will be published in 'Osteoporosis International', one of the field's most highly cited peer-reviewed journals. Delegates who submit abstracts may be eligible for scholarships and awards: further information is available at http://www.wco-iof-esceo.org/awards
-end-
For complete information visit http://www.wco-iof-esceo.org

An outstanding scientific programme is planned:

The scientific programme will include the following plenary lectures by renowned experts: Special topical multi-speaker sessions will focus on these important issues: To view the complete programme visit http://www.wco-iof-esceo.org/wednesday2

Online abstract submission, registration and hotel booking is available on the congress website: http://www.wco-iof-esceo.org

Key dates About IOF

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization devoted to the prevention, diagnosis and treatment of osteoporosis and related diseases of bone, muscles and joints. IOF members, including committees of scientific researchers, patient, medical and research societies, and industry representatives from around the globe, share a common vision of a world without musculoskeletal diseases and fragility fractures. IOF now represents more than 200 societies in all regions of the world. http://www.iofbonehealth.org / http://www.facebook.com/iofbonehealth / twitter.com/iofbonehealth

About ESCEO

The European Society for Clinical & Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. http://www.esceo.org

International Osteoporosis Foundation

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.